Recent attempts to treat Alzheimer’s disease have focused on enhancing acetylcholine function, using either cholinergic receptor agonists like nicotine or acetylcholinesterase inhibitors like physostigmine, velnacrine, tacrine, donepezil or metrifonate) to increase the concentration of acetylcholine in the neuronal synapses.